Quinolone carboxylic acid compositions and related methods of treatment

Details for Australian Patent Application No. 2002322002 (hide)

Owner Bausch & Lomb Incorporated

Inventors Takahashi, Masami; Asaoka, Takemitsu; Roy, Samir; Chandrasekaran, Santosh Kumar; Bowman, Lyle M.; Shibata, Akihiro; Imamori, Katsumi

Agent Spruson & Ferguson

Pub. Number AU-B-2002322002

PCT Number PCT/US02/12790

PCT Pub. Number WO2002/100309

Priority 10/126,513 22.04.02 US; 09/840,871 25.04.01 US

Filing date 24 April 2002

Wipo publication date 23 December 2002

Acceptance publication date 25 January 2007

International Classifications

A61K 9/06 (2006.01) Medicinal preparations characterised by special physical form - Ointments

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/08 (2006.01) Medicinal preparations characterised by special physical form - Solutions

A61K 9/10 (2006.01) Medicinal preparations characterised by special physical form - Dispersions

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61K 31/551 (2006.01) - having two nitrogens as ring hetero atoms, e.g. clozapine, dilazep

A61K 31/553 (2006.01) - having at least one nitrogen and at least one oxygen as ring hetero atoms, e.g. loxapine, staurosporine

A61K 31/554 (2006.01) - having at least one nitrogen and at least one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem

A61K 47/32 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds

A61K 47/40 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Cyclodextrins

A61P 27/02 (2006.01) Drugs for disorders of the senses

A61P 31/04 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

16 January 2003 Complete Application Filed

  Priority application(s): 10/126,513 22.04.02 US; 09/840,871 25.04.01 US

15 May 2003 Application Open to Public Inspection

  Published as AU-B-2002322002

11 November 2004 Assignment before Grant

  Insite Vision Incorporated; SSP Co., Ltd. The application has been assigned to Bausch & Lomb Incorporated; SSP Co., Ltd.

22 June 2006 Assignment before Grant

  Bausch & Lomb Incorporated; SSP Co., Ltd. The application has been assigned to Bausch & Lomb Incorporated

25 January 2007 Application Accepted

  Published as AU-B-2002322002

14 June 2007 Standard Patent Sealed

6 September 2007 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 08 Feb 2007. Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000

22 November 2007 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 08 Feb 2007

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002322003-METHOD OF ALIGNING OPTICAL FIBERS TO AN IOC

2002322001-GLYCEROL-PEG-DERIVATIVES AS INHIBITORS OF CYCLOOXYGENASE-2 AND PHOSPHOLIPASEA2